CPSC recall 14229
Panadol Advance® 100 count caplets
- CPSC
- unknown
- Published 2015-01-09
On 2015-01-09 the CPSC announced a recall of Panadol Advance® 100 count caplets by Glaxosmithkline Gsk, citing the packaging is not child-resistant as required by the Poison Prevention Packaging Act. These products contain acetaminophen which is required by the Poison Prevention Packaging….
| Agency | CPSC |
|---|---|
| Recall number | 14229 |
| Classification | Not classified |
| Status | unknown |
| Initiated | 2014-07-14 |
| Published | 2015-01-09 |
| Last updated | 2026-09-13 11:58 UTC |
| Company | Glaxosmithkline Gsk |
| Distribution | US |
Product
Panadol Advance® 100 count caplets | This recall involves bottles of 100ct Panadol Advance pain relievers. The medicine was sold in white containers with a blue label, inside a blue box. "Panadol" and "Advance" are printed on the label. Lot numbers and dates codes are located on the left side panel of the box and on the left side of the label on the bottle, near the bar code. Lot numbers and date codes included in the recall are: Lot number: 14241, expiration date: 02/2015 Lot number: 14002, expiration date: 10/2014 Lot number: 13881, expiration date: 09/2014 Lot number: 13801, expiration date: 09/2014
Reason
The packaging is not child-resistant as required by the Poison Prevention Packaging Act. These products contain acetaminophen which is required by the Poison Prevention Packaging Act to be sealed with child-resistant packaging.
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:58 UTC. Current status: unknown.
Source
Official record: https://www.cpsc.gov/Recalls/2014/GSK-Recalls-Panadol-Advance-Bottles
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.